IRIS
PANTANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.043
NA - Nord America 2.913
EU - Europa 1.266
SA - Sud America 383
AF - Africa 60
OC - Oceania 16
AN - Antartide 1
Totale 11.682
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.017
US - Stati Uniti d'America 2.795
CN - Cina 995
IT - Italia 606
HK - Hong Kong 584
BR - Brasile 274
FR - Francia 175
VN - Vietnam 153
GB - Regno Unito 143
DE - Germania 94
IN - India 80
CA - Canada 53
NL - Olanda 49
AR - Argentina 42
MX - Messico 39
ID - Indonesia 32
TR - Turchia 28
BD - Bangladesh 26
JP - Giappone 26
FI - Finlandia 24
RU - Federazione Russa 24
CZ - Repubblica Ceca 20
CO - Colombia 17
ES - Italia 17
PL - Polonia 16
SA - Arabia Saudita 16
ZA - Sudafrica 16
AU - Australia 15
UA - Ucraina 15
SE - Svezia 12
AT - Austria 11
EC - Ecuador 11
PY - Paraguay 10
EE - Estonia 9
IQ - Iraq 9
UZ - Uzbekistan 9
CL - Cile 8
PE - Perù 8
TN - Tunisia 8
VE - Venezuela 8
BH - Bahrain 7
CR - Costa Rica 7
JM - Giamaica 7
KR - Corea 7
MA - Marocco 7
PK - Pakistan 7
DZ - Algeria 6
LT - Lituania 6
MD - Moldavia 6
MY - Malesia 6
PH - Filippine 6
EG - Egitto 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
BE - Belgio 4
GR - Grecia 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
NP - Nepal 4
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
Totale 11.666
Salva come PNG Salva come JPEG
Città #
San Jose 973
Singapore 664
Ashburn 625
Hong Kong 583
Rome 434
Hefei 331
Beijing 268
Dallas 229
Boardman 173
Lauterbourg 149
London 116
Shanghai 114
Los Angeles 61
Ho Chi Minh City 50
Santa Clara 50
New York 44
Council Bluffs 42
Munich 40
San Francisco 40
Hanoi 35
Amsterdam 31
São Paulo 30
Mexico City 25
Pune 25
Brooklyn 23
Toronto 23
Orem 22
Brno 19
Seattle 18
Redmond 16
Montreal 15
Helsinki 14
Tokyo 14
Washington 14
Chicago 12
Warsaw 12
Frankfurt am Main 11
Chennai 10
Haiphong 10
Stockholm 10
Turku 10
Ankara 9
Hyderabad 9
Riyadh 9
Tashkent 9
Xi'an 9
Boston 8
Melbourne 8
Milan 8
San José 8
Biên Hòa 7
Johannesburg 7
Las Vegas 7
Manchester 7
Phoenix 7
Ribeirão Preto 7
Atlanta 6
Bologna 6
Canberra 6
Curitiba 6
Moscow 6
Naples 6
Paris 6
Rio de Janeiro 6
Asunción 5
Belo Horizonte 5
Buenos Aires 5
Campinas 5
Charlotte 5
Denver 5
Hamad Town 5
Hangzhou 5
Kingston 5
Miami 5
Mumbai 5
New Delhi 5
Yeonsu-gu 5
Bauru 4
Capaccio 4
Da Nang 4
Ha Long 4
Jakarta 4
Jeddah 4
Nairobi 4
Ninh Bình 4
Nuremberg 4
Oklahoma City 4
Padova 4
Philadelphia 4
Porto 4
Quito 4
Sona 4
Trieste 4
Vienna 4
West Jordan 4
Amman 3
Athens 3
Baghdad 3
Baku 3
Camaçari 3
Totale 5.704
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 292
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 256
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 246
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 244
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 234
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 232
Designing a broad-spectrum integrative approach for cancer prevention and treatment 231
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 230
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 221
Premetastatic niche: ready for new therapeutic interventions? 215
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 194
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 191
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 156
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 152
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 149
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 146
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 132
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 131
Anterior and posterior vaginal myomectomy: A new surgical technique 128
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 125
Biological effects of cabozantinib on bone microenvironment 125
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 125
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 125
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 124
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 123
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 119
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 118
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 117
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 117
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 117
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 115
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 115
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 114
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 114
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 114
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 110
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 109
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 104
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma 95
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 90
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 83
Role of c-mesenchymal-epithelial transition pathway in gastric cancer 81
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models 79
MicroRNAs and bone metastasis: a new challenge 75
Molecular prognostic factors in patients with pancreatic cancer 70
CETUXIMAB: From bench to bedside 62
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 61
New targets, new drugs for metastatic bone pain: a new philosophy 61
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 61
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 59
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients 57
Denosumab for cancer-related bone loss 57
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 57
The role of bone microenvironment, vitamin D and calcium 56
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 56
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 53
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation 53
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis 52
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 52
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone 52
Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis 50
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 50
Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence 50
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 50
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab 50
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study 50
New Technologies to Study the Interplay between Cancer Stem Cells and the Immune System 50
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence 49
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 49
Epidemiologia e caratteristiche delle metastasi ossee 49
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 49
Prognostic and predictive factors in pancreatic cancer 49
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 48
Clinical outcomes of metastatic renal carcinoma following disease progression to programmed death (PD)-1 or PD-L1 inhibitors (I-O): A Meet-URO group real-world study (Meet-Uro 7) 48
Network approach in liquidomics landscape 48
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis 47
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 47
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 47
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 47
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 47
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients 47
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 47
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 47
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 47
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 46
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs) 46
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 45
Targeting bone metastases starting from the preneoplastic niche: home sweet home 45
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 45
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 45
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature 44
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey 44
Regression of papillary thyroid cancer during nivolumab for renal cell cancer 44
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey 44
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 43
Monoclonal antibodies 43
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials. 43
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib 43
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus) 43
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 42
Totale 9.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.569
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 9 1 89 4 8 1 12 1 3 200
2022/202363 2 1 0 1 4 3 7 15 1 3 23 3
2023/2024508 16 49 30 31 50 224 6 20 6 24 16 36
2024/20255.748 76 92 206 49 39 137 115 31 491 456 1.794 2.262
2025/20265.171 484 226 397 511 249 349 1.457 401 454 539 104 0
Totale 11.818